Help Ensure Access to Paxlovid for COVID-19
You play a key role in limiting treatment delays with Paxlovid (nirmatrelvir/ritonavir) for patients with COVID-19.
Help HIGH-risk patients start within the 5-day window.
Dispensing. Any type of positive COVID-19 test is enough to qualify for Paxlovid, even a home test. And the med is still no cost to patients.